Table 3.
Histopathological assessment of pancreatic tissue across experimental groups. (mean ± SD, n = 10)
| group | edema | Inflammation | necrosis | Total |
|---|---|---|---|---|
| NC | 0.5 ± 0.53 | 0.3 ± 0.48 | 0 ± 0 | 0.8 ± 0.63 |
| SAP | 3.8 ± 0.42 | 3 ± 0.67 | 2.4 ± 0.52 | 9.2 ± 1.23 |
| SAP + Homo | 1.7 ± 0.67 | 1.1 ± 0.74 | 0.5 ± 0.53 | 3.3 ± 1.25 |
| shRNA-NC + SAP | 3.6 ± 0.52 | 2.92 ± 0.67 | 2.3 ± 0.48 | 8.9 ± 1.20 |
| shRNA-circDNMT3B + SAP | 3.9 ± 0.32 | 3.67 ± 0.49 | 3.4 ± 0.52 | 11 ± 0.94 |
| shRNA-NC + SAP + Homo | 1.2 ± 0.79 | 0.83 ± 0.72 | 0.4 ± 0.52 | 3 ± 1.33 |
| shRNA-circDNMT3B + SAP + Homo | 2 ± 0.67 | 1.92 ± 0.67 | 1.2 ± 0.42 | 4.7 ± 1.42 |
| shRNA-circDNMT3B + MIRi-NC + SAP + Homo | 2.1 ± 0.74 | 1.6 ± 0.7 | 1.4 ± 0.52 | 5.1 ± 1.73 |
| shRNA-circDNMT3B + MIRi-20b-5p + SAP + Homo | 1.5 ± 0.71 | 0.7 ± 0.48 | 0.3 ± 0.48 | 2.5 ± 1.08 |